Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
642 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT01245556 | Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma | completed | Phase 1 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00495066 | Compassionate Use Trial for Unresectable Melanoma With Ipilimumab | no longer available | — | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 5 | Bristol-Myers SquibbINDUSTRY | 5 | Jun 3, 2013 | clinicaltrials |
| NCT01413906 | Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors | completed | Phase 1 | 12 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00593944 | Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)(MDX1342-02) | completed | Phase 1 | 15 | Bristol-Myers SquibbINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT00944905 | Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) | completed | Phase 1 | 46 | Bristol-Myers SquibbINDUSTRY | 1 | May 22, 2013 | clinicaltrials |
| NCT00357461 | Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma | withdrawn | Phase 2 | 0 | Bristol-Myers SquibbINDUSTRY | 0 | May 15, 2013 | clinicaltrials |
| NCT00656734 | Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.(MDX1411-01) | completed | Phase 1 | 27 | Bristol-Myers SquibbINDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00385580 | Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer | completed | Phase 2 | 94 | Bristol-Myers SquibbINDUSTRY | 3 | Apr 30, 2013 | clinicaltrials |
| NCT00017043 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00024284 | Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 1 | — | Bristol-Myers SquibbINDUSTRY | 2 | Apr 5, 2013 | clinicaltrials |
| NCT00767520 | Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer | completed | Phase 2 | 155 | Bristol-Myers SquibbINDUSTRY | 8 | Feb 28, 2013 | clinicaltrials |
| NCT00634452 | Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma(MDX1401-01) | completed | Phase 1 | 22 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00948389 | Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) | terminated | Phase 1 / Phase 2 | 28 | Bristol-Myers SquibbINDUSTRY | 4 | Aug 31, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 21 | Bristol-Myers SquibbINDUSTRY | 3 | Jul 13, 2012 | clinicaltrials |
| NCT00083278 | Study of MDX-010 in Stage IV Breast Cancer | completed | Phase 2 | 33 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00101660 | Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib | completed | Phase 2 | 387 | Bristol-Myers SquibbINDUSTRY | 22 | Mar 2, 2012 | clinicaltrials |
| NCT01452334 | Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 23, 2012 | clinicaltrials |
| NCT01146171 | Japanese Phase 1 Study of BMS-844203 (CT322) | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01455103 | Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma(PD-L1) | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 0 | Dec 13, 2011 | clinicaltrials |
| NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | completed | Phase 1 | 25 | Bristol-Myers SquibbINDUSTRY | 2 | Nov 30, 2011 | clinicaltrials |
| NCT00898716 | Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan | completed | Phase 1 | 15 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00048581 | Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. | completed | Phase 3 | 738 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 21, 2011 | clinicaltrials |
| NCT00803374 | Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 21, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT00546780 | A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse(BMS TIME-1) | completed | Phase 3 | 31 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 28, 2011 | clinicaltrials |
| NCT00050596 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | completed | Phase 1 | 24 | Bristol-Myers SquibbINDUSTRY | 2 | May 4, 2011 | clinicaltrials |
| NCT00978731 | Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study | completed | Phase 1 | 46 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 28, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT01024101 | Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer | completed | Phase 2 | 36 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00099606 | Phase I (PH I) Mad Refractory Solid Tumor Study | completed | Phase 1 | 60 | Bristol-Myers SquibbINDUSTRY | 2 | Apr 19, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00057473 | A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00103701 | BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | completed | Phase 1 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00162214 | Study of Dasatinib in Patients With Advanced Solid Tumors | terminated | Phase 1 | 60 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00337454 | Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan | completed | Phase 1 / Phase 2 | 48 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | completed | Phase 2 | 55 | Bristol-Myers SquibbINDUSTRY | 4 | Mar 15, 2011 | clinicaltrials |
| NCT00050102 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT00326586 | A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer | completed | Phase 1 | 54 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00329004 | A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 89 | Bristol-Myers SquibbINDUSTRY | 4 | Jan 25, 2011 | clinicaltrials |
| NCT00390936 | A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 13 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00605618 | Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 8 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00644488 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | completed | Phase 1 | 7 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials